Background: Therapy based on medicinal cannabis or medical marijuana has attracted much international attention in recent years.Aim of the study: To assess the sale of medical marijuana in the Warminsko-Mazurskie Voivodeship between March 2019 and September 2020, estimate medical marijuana demand, and attempt to explain at least some of the reasons for the identified discrepancies.Material and methods: The study used data on medical marijuana sales in the Warminsko-Mazurskie Voivodeship collected by the Voivodeship Pharmaceutical Inspectorate in Olsztyn.Results: Medical marijuana is sold in trace amounts in the Warminsko-Mazurskie Voivodeship, although the available data indicate a dynamic increase in sales.Conclusions: Medical marijuana is available for sale in pharmacies in Poland in the form of pharmaceutical raw material. Currently, its sale, at least in the Warminsko-Mazurskie Voivodeship, is particularly small, though it is very likely that its future sales will increase. Despite this, there are no readily available reliable sources of information in Poland about the known benefits and dangers of medical marijuana use. In this situation, reliable knowledge needs to be disseminated to doctors and patients to safely achieve its therapeutic potential.

Background: The aim of this study is the analysis and estimation of the impact of the modification of the composition of extemporaneous preparation dispensed by the community pharmacy on their price value. The modification of ointment base, dosage form, active ingredient and excipient concentration, prescribing two separate preparations instead of double quantity of extemporaneous preparation, prices of the ingredients and packaging have been evaluated. Material and method: 1407 prescriptions have been prescribed by 330 doctors providing their practice in 212 medical institutions. On the basis of these prescriptions five community pharmacies situated in Olsztyn, Elblag, Paslek and Ilawa in Warmian-Masurian Voivodeship made 1407 extemporaneous preparations in 2011. The information contained in prescriptions has become a foundation for creating a database using MS Excel tool. Statistical analysis and arithmetic mean have been applied. Results: The average price value of the extemporaneous preparations in the test material amounts to PLN 34.05. The price value of 90% of the extemporaneous preparations is within PLN 15.89 – PLN 50.00 . The price value of 10% is above PLN 50.00 including 1% over PLN 100.00. The modification of the ointment base has triggered, on average, a 38% increase of the price value, the modification of dosage form - 37%, prescribing two separate preparations instead of double quantity of the extemporaneous preparation - 32%, modification of active ingredient concentration - 23%, modification of excipient concentration - 14%. The purchase prices of ingredients and packaging have not been uniform.